Semax / Selank vs Semax: prices, identity and regulatory status (2026)
Semax / Selank is a blend that includes Semax, so the two are compared as a blend and one of its listed components, not as substitutes: Semax / Selank is a blend of Semax and Selank; Semax is a 7-amino-acid peptide (C37H51N9O10S). Neither product has a current in-stock price right now.
Semax / Selank vs Semax: current prices and packages
| Compared property | Semax / Selank | Semax |
|---|---|---|
| Category | Cognitive | Cognitive |
| Compared package | 10/10mg | 10mg |
| Lowest current price | No current in-stock price | No current in-stock price |
| Price per labelled mg | — | — |
| Package sizes | 5/5mg, 10/10mg, 15/15mg | 5mg, 10mg, 25mg, 30mg, 50mg |
| Vendors with current prices | 0 | 0 |
| Form at this package | No listing | No listing |
| Stock | Out of stock | Out of stock |
Prices exclude shipping. The price per labelled mg is always given per mg, so different package sizes compare directly; it is shown only for single-compound vials and powders with a labelled mass. Blends, capsules, liquids and IU-labelled packages are compared by package total.
Identity, regulatory status and registered research
| Compared property | Semax / Selank | Semax |
|---|---|---|
| Molecular formula | Blend: Semax, Selank | C37H51N9O10S |
| Molecular weight | — | 813.9 g/mol |
| Sequence | — | H-Met-Glu-His-Phe-Pro-Gly-Pro-OH (7 residues) |
| CAS Registry Number | — | 80714-61-0 |
| Registered clinical trials | None recorded | None recorded |
| Human intervention studies | None recorded | 4 |
| US regulatory status | No reviewed Drugs@FDA record | No reviewed Drugs@FDA record |
Identity data: PubChem, FDA GSRS and EPA records; registry counts: ClinicalTrials.gov; status: Drugs@FDA. A matching name does not verify the contents of a supplier's lot.
Key human studies
Semax / Selank
No human intervention study is recorded in the research library for this identity.
Semax / Selank research profile →Semax
- [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2018
- [The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007
- [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease]. Vestnik oftalmologii, 2000
Studies are listed as records, newest first; they are not evidence that a research product is safe or effective.
Where to buy each compound
Semax / Selank
Semax / Selank is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
No vendor has a current in-stock price for this package.
Semax / Selank prices →Price history →Semax
Semax is a catalogue entry whose compound-specific reference review has not yet been completed.
No vendor has a current in-stock price for this package.
Semax prices →Price history →Related comparisons
Questions
Automated price sources are scheduled daily; other sources are checked manually. Check the offer's last successful source timestamp. A code is shown when it is attached to an offer or affiliate link. The displayed price includes a discount only when that code is cart-verified and the discounted price is explicitly recorded; otherwise it is the vendor's listed price. Prices exclude shipping. Stock status is captured at the same time. Rankings are by displayed price, except that the labelled featured partner, LA Peptides, is pinned first; “Cheapest” always marks the lowest price. PeptideTech earns a commission when you buy through a link.
Full method →